Ainnocence and Phase Advance Enter Industry-First AI Collab to Reduce Drug Development Timeline and Clinical Trial Risk

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Nasdaq

4D Molecular Therapeutics Accelerates Phase 3 Trial Timelines for 4D-150 in Wet AMD and Streamlines Operations

4D Molecular Therapeutics announced an acceleration in the timeline for its 4FRONT-1 Phase 3 trial data readout of the 4D-150 treatment for wet age-related macular degeneration (AMD), now expected in ...
Nasdaq

Kiniksa Pharmaceuticals Announces Phase 2/3 Trial Timeline for KPL-387 in Recurrent Pericarditis

Kiniksa Pharmaceuticals announces Phase 2/3 trial for KPL-387, targeting recurrent pericarditis, expected mid-2025. Data available in late 2026. Kiniksa Pharmaceuticals announced that it is set to ...
Seeking Alpha

Vistagen advances Phase 3 SAD trials with 2025 data readout target

CEO Shawn Singh outlined the company’s progress on its lead clinical programs, particularly fasedienol, which is being developed for the acute treatment of social anxiety disorder (SAD). Singh ...
Contract Pharma

Navigating The Highs and Lows of Early Phase Clinical Trials

Early-phase clinical trials, those first-in-human studies, are where years of research and millions in investment meet the ...